Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Anticancer Agents : Design, Synthesis and Evaluation
| Anticancer Agents : Design, Synthesis and Evaluation |
| Autore | Chen Qiao-Hong |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (606 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
1,2,3-triazole
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide 3,6-dibromocarbazole 4-(pyridin-4-yloxy)benzamide 5-bromoindole 5-fluorouracil ABCB1 (P-glycoprotein) actin ADME allene amides/esters androgen receptor anti-cancer activity anti-neuroinflammation anti-ovarian cancer anti-tumor anticancer anticancer activity anticancer agent anticancer agents anticancer compounds antimitotic agents antioxidant activity antiproliferative activity antiproliferative agent antitumor antitumor activity apalutamide apoptosis aromatase benzimidazole benzofuran-pyrazole benzofurans beta-lapachone bivalency breast cancer c-Met carbazole cell cycle chemical synthesis chemoresistance chrysin analogues colchiceine colchicine amide colchicine analogs colchicine sulfonamide colon cancer computational docking coumarin crystal structure cyanopyridone cytotoxic activity cytotoxic properties cytotoxicity darolutamide DFT study dihydroartemisinin dihydropyranoindole docking docking studies drug discovery drug resistance E-stereoselective enzalutamide enzyme inhibition estrone derivatives flavonoid flavonoids gemcitabine HDAC inhibitors HeLa HepG2 hydrates hydrazine IGF-1R IL-12 immune modulation indoleamine 2,3-dioxygenase inflammation inhibitor K562 kinase inhibitor MCF-7 MDM2-p53 interaction migration mimetics molecular simulation MOLT-4 multidrug resistance (MDR) reversal N-substituted pyrazoline nanoparticles natural product neuroblastoma NIH3T3 o-nitro-benzyl organosilicon compounds ortho-quinones ovarian cancer overcoming drug resistance P-glycoprotein P-MAPA PARP inhibitor PARP-1 inhibition phenylpyrazolopyrimidine photoactivatable protecting groups PI3Ks PI3Kα inhibitor PI3Kδ inhibitors polyvalency prodrug prostate cancer PROTACs protein degradation protein kinase protein-protein interactions Pyrazole pyrazolopyridine pyridotriazine quinazolin-4(3H)-one quinazolin-4(3H)-thione regioselective salinomycin Schiff base SILA-409 (Alis-409) SILA-421 (Alis-421) Src substituted pyridine synergy synthesis Talazoparib tanshione IIA taxoids thiazolidinone Thienopyrimidine thienopyrimidinone thiocolchicine thiopene thioxotriazopyridine TLR signaling topoisomerase II inhibitor triazolothiadiazine triple-negative breast cancer tryptophan metabolism tubulin inhibitors tumor specificity urea virtual screening xanthones yeast-based assays zampanolide βIII-tubulin |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Anticancer Agents |
| Record Nr. | UNINA-9910557129103321 |
Chen Qiao-Hong
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
| Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination |
| Autore | Alix-Panabieres Catherine |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (366 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
abiraterone
ACCEPT androgen receptor AR AR-V7 ARV7 biomarker biomarkers bone marrow breast cancer castration resistant prostate cancer (CRPC) CD133 CellSearch CellSearch® cerebrospinal liquid biopsy chemoradioresistance chromogranin A circulating leukemia cells circulating plasma cells circulating tumor cells circulating tumor cells (CTC) circulating tumor cells (CTCs) circulating tumor DNA circulating tumour cells clinical trials clinical utility colorectal cancer colorectal surgery CTC CTC biology CTC capture technology CTC-based treatment decisions CTC-derived ex vivo models CTC-derived xenografts CTCs ctDNA CTM CTMat ctRNA disseminated tumor cells early breast cancer EasyCount slides emboli enrichment and detection technologies enzalutamide EpCAM enrichment EPISPOT epithelial-mesenchymal transition epithelial-to-mesenchymal transition (EMT) exosome exosomes fibronectin fish flow cytometry FOLFIRINOX gene expression analysis glioma hematological cells hepatocellular carcinoma (HCC) heterogeneity HMB-45 immune checkpoint inhibitors immune system immunofluorescence imaging immunomodulation immunophenotyping in vivo flow cytometry integrin B1 leukocyte-derived extracellular vesicles liquid biopsy liquid surgery locally advanced rectal cancer major histocompatibility complex class I (MHCI) malaria melanoma metastasis metastatic colorectal cancer microbiome microfluidics microsatellite instability miRNA n/a neutrophils NSCLC PD-L1 expression platelets prostate cancer prostate cancer (PCa) RAD23B rovalpituzumab tesirine rVAR2 single-cell analysis SLUG small-cell lung carcinoma solid cancers stem cells synaptophysin targeted therapy thymidylate synthase tumor biomarkers tumor cell dissemination tumor stem cells tumor-initiating cells (TICs) xenograft models |
| ISBN | 3-03928-699-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Circulating Tumor Cells |
| Record Nr. | UNINA-9910404091403321 |
|
Alix-Panabieres Catherine
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cytobiology of Human Prostate Cancer Cells and Its Clinical Applications
| Cytobiology of Human Prostate Cancer Cells and Its Clinical Applications |
| Autore | Ishii Kenichiro |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (184 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
abiraterone
AKR1C3 androgen deprivation therapy androgen receptor androgen receptor dependency androgen sensitivity animal model apoptosis autophagy cabazitaxel CAF castration resistant prostate cancer castration-resistant prostate cancer Caveolin-1 CCL2 CCL22 CCL5 chemotherapy CW069 cytokine diet docetaxel docetaxel resistance enzalutamide EPI-002 epigenetics fat fibroblast fibroblast growth factor fibroblast growth factor receptor fibroblast-dependent androgen receptor activation fibroblasts G1 cell cycle arrest high-fat diet hormone-naïve prostate cancer immune cells immunohistochemistry in vitro in vivo inflammation KIFC1 LSD1 migration mouse n/a obesity P-glycoprotein pirfenidone prostate cancer prostate-specific antigen radiotherapy resistance splice variant testosterone TGFβ1 time to PSA nadir tissue microarray TP53-regulated inhibitor of apoptosis 1 tumour microenvironment tumour stroma |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557116703321 |
|
Ishii Kenichiro
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Free Radical Research in Cancer
| Free Radical Research in Cancer |
| Autore | Čipak Gašparović Ana |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (192 p.) |
| Soggetto topico | Technology: general issues |
| Soggetto non controllato |
4-hydroxy-2-nonenal
5-Fluorouracil androgen deprivation therapy androgen receptor (AR), AR-V7 anti-androgen antioxidant antioxidant proteins antioxidant therapy antioxidants ascorbate ayurveda bardoxolone methyl bleomycin breast cancer breast cancer stem cells calcium channel cancer cancer chemotherapy cancer metabolism cancer treatment carbonylation castration-resistant prostate cancer cell death chemoprevention and chemotherapy chemoresistance chemotherapy-induced toxicity cisplatin combination therapy deferasirox doxorubicin enzalutamide extracellular matrix free radicals granulosa cell tumor lapachone light lung cancer menadione methotrexate mitochondria myelodysplastic syndromes n/a new therapeutic strategies nitric oxide NQO1 NQO1*2 NRF2 ovary oxaliplatin oxidative stress ozone therapy photodynamic therapy polymorphism prostate cancer quinone reactive oxygen species reactive oxygen species (ROS) singlet oxygen sperm therapy resistance triphala Trolox |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557152603321 |
|
Čipak Gašparović Ana
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Urological Cancer 2021
| Urological Cancer 2021 |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (328 p.) |
| Soggetto topico |
Chemistry
Research & information: general |
| Soggetto non controllato |
177Lu-PSMA
abiraterone ablation margins advanced urothelial carcinoma AHNAK2 autopsy Bacillus Calmette-Guérin (BCG) biomarker biomarkers biopsy bladder cancer bladder cancer cell lines bladder carcinoma cancer cell migration comparative effectiveness comparative oncology ctDNA decision making diagnosis divergent differentiation docetaxel dog enzalutamide epiplakin epithelial-mesenchymal transition fluorescence confocal microscopy focal therapy frail patients frailty FTY-720 game theory genomic analysis genomic signatures glutaminase Hounsfield units image-guided immune checkpoint inhibitor immune checkpoint inhibitors immunohistochemistry immunotherapy in situ methods inflammation inflammatory indices latent cancer liquid biopsy machine learning magnetic resonance imaging mCRPC metastasectomy metastasis metastatic prostate cancer microenvironment molecular subtypes mortality n/a novel hormonal therapies OIP5 oncological outcomes papillary renal cell carcinoma PD-1 PD-L1 PLK1 positron-emission tomography postoperative complications preclinical studies prediction model preneoplastic lesion prognosis prognostic prognostic factor prognostic index prostate prostate biopsy prostate cancer prostatic atrophy prostatic neoplasms PSA PSMA-RLT psoas muscle radical cystectomy radiosensitisation radiotherapy real-world treatment pattern renal cell carcinoma screening trial sphingosine 1-phosphate receptor 1 stereotactic body radiotherapy survival therapy TRIPOD tumor ecology tumor thrombus tumorigenesis tumour mutational board ultrasonography urinary bladder neoplasms urine urothelial carcinoma variant morphology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576872803321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||